KARD Kardigan, Inc.
Nasdaq · SEC CIK 2123613 · EDGAR
- Bought, last 12 months
- $90.00M 3 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 16 since 2026-06-22, latest 2026-07-13 16:44
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| HRTG GPE, LLC | 10% | $50.00M | — |
| ARCH Venture Partners XIII, LLC | Dir, 10% | $20.00M | — |
| BERNS PAUL L | Dir, 10% | $20.00M | — |
| Edelberg Jay | Chief Medical Off | — | — |
| Jahn Brianne | CFO | — | — |
| Pasternak Andy | Chief Strategy Off | — | — |
| Moriarty John B | CLO | — | — |
| Giordano Douglas E. | Dir | — | — |
| GIANAKAKOS ANASTASIOS | Pres, CEO, Dir | — | — |
| Meeker David P | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-07-13 16:44 | 2026-06-17 | KARD | PERCEPTIVE ADVISORS LLC | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| I | 2026-06-24 21:26 | 2026-06-22 | KARD | HRTG GPE, LLC | 10% | P - Purchase | $16.00 | +3.12M | 14.87M | +27% | +$50.00M |
| I | 2026-06-24 16:20 | 2026-06-22 | KARD | BERNS PAUL L | Dir, 10% | P - Purchase | $16.00 | +1.25M | 15.04M | +9% | +$20.00M |
| I | 2026-06-24 16:18 | 2026-06-22 | KARD | ARCH Venture Partners XIII, LLC | Dir, 10% | P - Purchase | $16.00 | +1.25M | 15.04M | +9% | +$20.00M |
| DMI | 2026-06-22 21:57 | 2026-06-17 | KARD | HRTG GPE, LLC | 10% | C - Cnv Deriv | — | +13.79M | 11.74M | New | — |
| DI | 2026-06-22 19:39 | 2026-06-17 | KARD | ARCH Venture Partners XIII, LLC | Dir, 10% | C - Cnv Deriv | — | +13.79M | 13.79M | New | — |
| 2026-06-22 19:30 | 2026-06-17 | KARD | Pasternak Andy | Chief Strategy Off | A - Grant | $0.00 | +79.6K | 79.6K | New | $0 | |
| 2026-06-22 19:28 | 2026-06-17 | KARD | Meeker David P | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 | |
| DI | 2026-06-22 19:24 | 2026-06-17 | KARD | BERNS PAUL L | Dir, 10% | C - Cnv Deriv | — | +13.79M | 13.79M | New | — |
| D | 2026-06-22 19:24 | 2026-06-17 | KARD | BERNS PAUL L | Dir, 10% | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| 2026-06-22 19:23 | 2026-06-17 | KARD | Moriarty John B | CLO | A - Grant | $0.00 | +47.8K | 47.8K | New | $0 | |
| 2026-06-22 19:20 | 2026-06-17 | KARD | Jahn Brianne | CFO | A - Grant | $0.00 | +79.6K | 79.6K | New | $0 | |
| 2026-06-22 19:19 | 2026-06-17 | KARD | Popovits Kimberly J | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 | |
| D | 2026-06-22 19:17 | 2026-06-17 | KARD | Walbert Timothy P | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| DMI | 2026-06-22 19:17 | 2026-06-17 | KARD | GIANAKAKOS ANASTASIOS | Pres, CEO, Dir | C - Cnv Deriv | — | +568.4K | 498.7K | New | — |
| 2026-06-22 19:15 | 2026-06-17 | KARD | Giordano Douglas E. | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 | |
| D | 2026-06-22 19:14 | 2026-06-17 | KARD | Edelberg Jay | Chief Medical Off | C - Cnv Deriv | — | +97.6K | 135.5K | +257% | — |
| D | 2026-06-22 19:14 | 2026-06-17 | KARD | Edelberg Jay | Chief Medical Off | A - Grant | $0.00 | +47.8K | 183.3K | +35% | $0 |
Purchase Sale Sale after option exercise All abbreviations